Tempus AI (NASDAQ:TEM) CEO Sells $1,000,800.00 in Stock

Posted by Brenda Bartman on Aug 14th, 2026

Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) CEO Ryan Fukushima sold 20,000 shares of Tempus AI stock in a transaction on Friday, August 7th. The stock was sold at an average price of $50.04, for a total value of $1,000,800.00. Following the sale, the chief executive officer owned 123,945 shares in the company, valued at $6,202,207.80. The trade was a 13.89% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Ryan Fukushima also recently made the following trade(s):

On Monday, August 3rd, Ryan Fukushima sold 23,818 shares of Tempus AI stock. The stock was sold at an average price of $46.19, for a total transaction of $1,100,153.42.
On Wednesday, July 8th, Ryan Fukushima sold 33,284 shares of Tempus AI stock. The stock was sold at an average price of $57.39, for a total transaction of $1,910,168.76.
On Monday, July 6th, Ryan Fukushima sold 10,000 shares of Tempus AI stock. The stock was sold at an average price of $60.00, for a total transaction of $600,000.00.
On Tuesday, May 19th, Ryan Fukushima sold 13,550 shares of Tempus AI stock. The shares were sold at an average price of $44.07, for a total transaction of $597,148.50.

Tempus AI Stock Down 0.6%

Tempus AI stock opened at $54.29 on Friday. Tempus AI, Inc. has a twelve month low of $40.77 and a twelve month high of $104.32. The firm has a 50 day moving average price of $51.68 and a 200-day moving average price of $51.50. The company has a market capitalization of $9.80 billion, a P/E ratio of -37.70 and a beta of 3.58. The company has a quick ratio of 3.16, a current ratio of 3.30 and a debt-to-equity ratio of 3.06.

Tempus AI (NASDAQ:TEM – Get Free Report) last posted its quarterly earnings results on Thursday, July 30th. The company reported ($0.04) EPS for the quarter, topping analysts’ consensus estimates of ($0.14) by $0.10. Tempus AI had a negative net margin of 17.77% and a negative return on equity of 50.28%. The company had revenue of $382.49 million for the quarter, compared to analysts’ expectations of $379.69 million. During the same quarter in the previous year, the firm posted ($0.22) EPS. Tempus AI’s revenue was up 21.6% on a year-over-year basis. As a group, equities analysts predict that Tempus AI, Inc. will post -1.38 EPS for the current year.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the company. Lake Street Capital lowered Tempus AI to a “hold” rating in a report on Monday, July 20th. Guggenheim increased their target price on shares of Tempus AI from $60.00 to $65.00 and gave the stock a “buy” rating in a research report on Thursday, July 16th. TD Cowen reiterated a “buy” rating on shares of Tempus AI in a research note on Wednesday, July 15th. Weiss Ratings raised shares of Tempus AI from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday. Finally, Needham & Company LLC restated a “buy” rating and set a $75.00 price target on shares of Tempus AI in a research note on Friday, July 31st. Nine research analysts have rated the stock with a Buy rating, six have given a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, Tempus AI has an average rating of “Hold” and an average target price of $64.92.

Read Our Latest Research Report on Tempus AI

Institutional Trading of Tempus AI

A number of hedge funds and other institutional investors have recently bought and sold shares of TEM. JPL Wealth Management LLC purchased a new position in shares of Tempus AI during the third quarter worth about $26,000. Los Angeles Capital Management LLC bought a new stake in Tempus AI during the fourth quarter valued at approximately $27,000. Harvest Fund Management Co. Ltd purchased a new position in Tempus AI in the 3rd quarter worth approximately $38,000. Whittier Trust Co. grew its stake in Tempus AI by 190.0% in the 1st quarter. Whittier Trust Co. now owns 870 shares of the company’s stock worth $41,000 after buying an additional 570 shares in the last quarter. Finally, EverSource Wealth Advisors LLC increased its holdings in shares of Tempus AI by 88.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 691 shares of the company’s stock worth $44,000 after buying an additional 325 shares during the last quarter. Institutional investors own 24.22% of the company’s stock.

About Tempus AI

(Get Free Report)

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.